Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company is headquartered in The Woodlands, Texas.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-17.49M |
| Operating Margin | 0.00% |
| Return on Equity | -188.70% |
| Return on Assets | -99.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.75 |
| Price-to-Book | 0.52 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.41M |
| Float | $11.06M |
| % Insiders | 4.06% |
| % Institutions | 2.51% |